Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2008-6-19
pubmed:abstractText
Toll-like receptors (TLRs) play an important role in innate immunity while, beta(2)-adrenergic receptors (beta(2)AR) provide the key linkages for the sympathetic nervous system to regulate the immune system. However, their role in macrophages remains uncertain. Here, we demonstrate the cross-talk between beta(2)AR and TLR signalling pathways. Expression of beta(2)AR was down-regulated by TLR4 ligand lipopolysaccharide (LPS) stimulation. To investigate the physiological consequence of this down-regulation RAW264 cells, a macrophage cell line, were transfected with a beta(2)AR expression vector (RAWar). Both LPS-stimulated inducible nitric oxide synthase (NOS II) expression and NO production were markedly suppressed in the RAWar cells. The activation of nuclear factor-kappaB (NF-kappaB) and degradation of the inhibitor of NF-kappaB (IkappaBalpha) in response to LPS were markedly decreased in these cells. The level of beta-arrestin 2, which regulates beta(2)AR signalling, was also reduced in RAW264 cells after stimulation with LPS, but not in RAWar cells. Overexpression of beta-arrestin 2 (RAWarr2) also inhibited NO production and NOS II expression. Furthermore, we demonstrated that beta-arrestin 2 interacted with cytosolic IkappaBalpha and that the level of IkappaBalpha coimmunoprecipitated by anti-beta-arrestin 2 antibodies was decreased in the RAW264 cells but not in RAWar or RAWarr2 cells. These findings suggest that LPS-stimulated signals suppress beta(2)AR expression, leading to down-regulation of beta-arrestin 2 expression, which stabilizes cytosolic IkappaBalpha and inhibits the NF-kappaB activation essential for NOS II expression, probably to ensure rapid and sufficient production of NO in response to microbial attack.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18194271-10085161, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194271-10102628, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194271-10825740, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194271-10914486, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194271-10973280, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194271-11121511, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194271-11577346, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194271-11734616, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194271-11741294, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194271-11861602, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194271-11861753, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194271-12032308, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194271-12089332, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194271-12370187, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194271-12524386, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194271-12925697, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194271-15125834, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194271-15173580, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194271-15336560, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194271-16136188, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194271-16368719, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194271-17121833, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194271-2263644, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194271-3139757, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194271-8553074, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194271-9500794, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194271-9548485
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1365-2567
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
124
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
348-56
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Beta2-adrenergic receptor regulates Toll-like receptor-4-induced nuclear factor-kappaB activation through beta-arrestin 2.
pubmed:affiliation
Department of Molecular Predictive Medicine and Sport Science, Kyorin University, School of Medicine, Mitaka, Japan. kizaki@kyorin-u.ac.jp
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't